Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 24, Issue 3, 2000, Pages 455-462

  Decker, Sarah ^a   Grider, Glenna ^a   Cobb, Mahoney ^a   Li, Xiao Ping ^a   Huff, Mary O ^a   El Mallakh, Rif S ^a   Levy, Robert S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Activity monitor; Animal model; Bipolar disorder; Manic depression; Open field; Ouabain

Indexed keywords

OUABAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; CONTROLLED STUDY; DEPRESSION; LOCOMOTION; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; RAT;

ANIMALS; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; MALE; MOVEMENT DISORDERS; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034177404     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00111-6     Document Type: Article

References (14)

1. Changaris, D.G., Porter, J.L., Miller, J.J., and Levy, R.S. (1988). Des-Leu angiotensin I: Biosynthesis and drinking response. Regul. Pept. 20:273-280.
2. Cooper, D.A., Piper, D.C., Upton, N., and Leslie, R.A. (1996). The effect of lithium on the hypermotility response to the central administration of ouabain in the rat. Br. J. Pharmacol. 118 (Suppl.): 62P.
3. El-Mallakh, R.S. (1997a). Bipolar illness. South. Med. J. 90: 775-779.
4. El-Mallakh, R.S. (1997b). New insights into the course and prognosis of bipolar illness. Psychiatric Ann. 27:478-481.
5. El-Mallakh, R.S., Harrison, L.T., Li, R., Changaris, D.G., and Levy, R.S. (1995). An animal model for mania: Preliminary results. Prog. NeuroPsychopharmacol. & Biol. Psychiatry 19:955-962.
6. El-Mallakh, R.S., and Wyatt, R.J. (1995). The Na,K-ATPase hypothesis for bipolar illness. Biol. Psychiatry 37:235-244.
7. Fisher, A. (1992). Violence and victims in the psychiatric setting. In: Psychiatric Nursing. Wilson, H.S., and Kneisl, C.R. (eds), pp. 489-507.
8. Goodwin, F.K., and Jamison, K.R. (1990). Manic Depressive Illness. Oxford University Press, New York.
9. Hayden, J.F., Johnson, L.R., and Maickel, R.P. (1966). Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain. Life Sci. 5: 1509-1515.
10. Li, R., El-Mallakh, R.S., Harrison, L.T., Changaris, D.G., and Levy, R.S. (1997). Lithium prevents ouabain-induced behavioral changes: Towards an animal model for manic depression. Mol. Chem. Neuropathol. 31:65-72.
11. Looney, S.W., and El-Mallakh, R.S. (1997). Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress. Anxiety 5:53-65.
12. Piper, D.C., Cooper, D.A., and Upton, N. (1996). The effect of antimanic drugs on the hyperlocomotor response to ICV administration of ouabain in the rat. Presented at the Annual Meeting of the European College of Neuropsychopharmacology, Amsterdam, the Netherlands.
13. Rose, A.M., Mellett, B.J., Valdes, R., Jr., Kleinman, J.E., Herman, M.M., Li, R., and El-Mallakh, R.S. (1998). Alpha2 isoform of Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol. Psychiatry 44:892-897.
14. Ruktanonchai, D.J., El-Mallakh, R.S., Li, R., and Levy, R.S. (1998). Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol. Behav. 63:403-406.